Changjiang Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 40.73% vs -45.85% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -101.15% vs 41.72% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.90",
          "val2": "24.80",
          "chgp": "40.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-100.30",
          "val2": "-49.70",
          "chgp": "-101.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-104.80",
          "val2": "-52.10",
          "chgp": "-101.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,876.60%",
          "val2": "-2,436.10%",
          "chgp": "-44.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -90.67% vs -25.75% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -103.41% vs -1,685.87% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "111.60",
          "val2": "1,196.40",
          "chgp": "-90.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-734.40",
          "val2": "-95.80",
          "chgp": "-666.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "111.30",
          "val2": "61.50",
          "chgp": "80.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-451.40",
          "val2": "-477.20",
          "chgp": "5.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,438.70",
          "val2": "-707.30",
          "chgp": "-103.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6,917.30%",
          "val2": "-119.20%",
          "chgp": "-679.81%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

34.90

24.80

40.73%

Operating Profit (PBDIT) excl Other Income

-100.30

-49.70

-101.81%

Interest

3.60

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

-104.80

-52.10

-101.15%

Operating Profit Margin (Excl OI)

-2,876.60%

-2,436.10%

-44.05%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 40.73% vs -45.85% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -101.15% vs 41.72% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

111.60

1,196.40

-90.67%

Operating Profit (PBDIT) excl Other Income

-734.40

-95.80

-666.60%

Interest

111.30

61.50

80.98%

Exceptional Items

-451.40

-477.20

5.41%

Consolidate Net Profit

-1,438.70

-707.30

-103.41%

Operating Profit Margin (Excl OI)

-6,917.30%

-119.20%

-679.81%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -90.67% vs -25.75% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -103.41% vs -1,685.87% in Dec 2023

All Annual Results